menu
    • menu

    Company profile for Clinuvel Pharmaceuticals

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global biopharmaceutical company committed to developing drugs for the treatment of a range of severe skin disorders. People conceptualise ideas and products, and at CLINUVEL the integrity and quality of people – in that particular order – leads to meaningful outcomes, successes and eventually products to serve patients and a wider audience of users. At CLINUVEL there is a deep reservoir of expert knowledge beyond...
    We are a global biopharmaceutical company committed to developing drugs for the treatment of a range of severe skin disorders. People conceptualise ideas and products, and at CLINUVEL the integrity and quality of people – in that particular order – leads to meaningful outcomes, successes and eventually products to serve patients and a wider audience of users. At CLINUVEL there is a deep reservoir of expert knowledge beyond the realm of this history and future to the company. We aim to use our knowledge to innovate products for smaller patient populations and larger audiences.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clinuvel PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 11, 535 Bourke st, Melbourne Victoria 3000
    Telephone
    Telephone
    +44 1372 860 765
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clinuvel.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clinuvel-pharmaceuticals-ltd
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ClinuvelNews

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinuvel Gets Ema's Final Scientific Advice For Key Vitiligo
    Clinuvel Gets Ema's Final Scientific Advice For Key Vitiligo

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3280522/0/en/clinuvel-receives-final-ema-scientific-advice-for-pivotal-phase-iii-vitiligo-study.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    CLINUVEL Upgrades ADR Program to Level II, Uplists Nasdaq
    CLINUVEL Upgrades ADR Program to Level II, Uplists Nasdaq

    22 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/22/3137673/0/en/CLINUVEL-preparing-upgrade-of-ADR-program-to-Level-II-Nasdaq-uplist.html

    GLOBENEWSWIRE
    22 Aug 2025
    Share Share
    Clinuvel recruits 200 patients in Phase III vitiligo trial CUV105
    Clinuvel recruits 200 patients in Phase III vitiligo trial CUV105

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075714/0/en/CLINUVEL-recruits-200-patients-in-Phase-III-vitiligo-trial-CUV105.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Clinuvel Unveils Vitiligo Program At AAD 2025 Dermatology Meeting
    Clinuvel Unveils Vitiligo Program At AAD 2025 Dermatology Meeting

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/04/3036144/0/en/Clinuvel-Introduces-Groundbreaking-Vitiligo-Program-at-the-World-s-Biggest-Dermatology-Meeting-AAD-2025.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share
    Afamelanotide in fair-skinned Parkinson’s patients
    Afamelanotide in fair-skinned Parkinson’s patients

    17 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900070/0/en/Afamelanotide-in-fair-skinned-Parkinson-s-patients.html

    GLOBENEWSWIRE
    17 Jun 2024
    Share Share
    Photomedicine CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
    Photomedicine CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2853764/0/en/Photomedicine-Pioneer-CLINUVEL-Unveils-Clinical-Cosmetic-Ambitions-to-German-Investors.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search